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Activated protein C (APC), a physiological coagulationinhibitor, has been shown to
reduce mortality in patients with severe sepsis. APC exerts pleiotropic
cytoprotection by a mechanism that requires its interaction with endothelial cell
protein C receptor and protease-activated receptor-1 on target cells. In the previous
issue, Pérez-Casal and colleagues elegantly demonstrate that APC, using its
recombinant form (rhAPC), can communicate to target cells through release of
microparticles (MPs), small membrane vesicles released from activated cells, to
induce antiapoptotic and anti-infl ammatory properties that might participate in the
improvement of patient outcome. Of interest is the fact that APC itself promotes the
release of MPs from target cells including endothelial cells and monocytes. These
MPs bear the endothelial cell protein C receptor/APC molecules and can transfer
the message to target cells including those of origin to induce cytoprotection. The
long-range APC signal can thus be mediated by MPs in vivo upon pharmacological
treatment using rhAPC in severe septic patients. A novel pharmacological approach
targeting MP production and properties could therefore be used to treat severe
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